Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03578523
Other study ID # 15040
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date October 2015
Est. completion date December 2020

Study information

Verified date July 2018
Source University of Nottingham
Contact Huda Mahmoud, MBChB
Phone 01332724365
Email huda.mahmoud@nottingham.ac.uk
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

To use Non-invasive MR Imaging of Renal Physiology and structure to assess patients with Acute Kidney Injury (AKI) and Chronic Kidney Disease (CKD).


Description:

Multi centre observational pilot study using novel, contrast free functional renal MRI scans.

A series of functional renal MRI scans will be performed (These scans do not constitute part patients routine clinical care). The results will initially be used to assess renal perfusion and fibrosis in patients with AKI and CKD. Subsequent analysis will be used to identify specific markers on the renal MRI scans that differentiate chronic kidney damage from acute injury to the kidney. Finally results will be used to stratify patients with AKI and CKD into low and high risk of subsequent deterioration in renal function.

AKI Cohort

25 patients with AKI stage 2/3 with or without renal replacement therapy (RRT) will undergo functional renal MRI imaging at day 0, day 90 and day 365.

First Study Scan (Day 0): A functional renal MRI scan will be performed during an admission to hospital with an episode of AKI 2/3. Vital signs and SOFA score will be recorded on the day of the scan.

Renal function assessment will occur± 2 days either side of the scan with an Iohexol clearance test.

Second Study Scan (Day 90): Repeat functional renal MRI imaging will be planned at 90 days (±14 days) after the 1st study scan day.

Renal function assessment will occur±7 days either side of the scan with an Iohexol clearance test.

Third Study Scan (Day 365): The final functional renal MRI imaging will take place 12 months (±30 days) after the 1st study scan day. Renal function assessment will occur±7 days either side of the scan with an Iohexol clearance test.

CKD Cohort:

25 patients with CKD stage 3-4 eGFR 20-59ml/min/1.73m2 will undergo functional renal MRI imaging at day 0, day 7 and day 365.

First Study Scan (Day 0): A functional renal MRI scan will be performed as an outpatient. Vital signs will be recorded on the day of the scan.

Renal function assessment will occur ±7 days either side of the scan with an Iohexol clearance test.

Second Study Scan (Day 7): A functional renal MRI scan will be performed as an outpatient. Vital signs will be recorded on the day of the scan.

Third Study Scan (Day 365): The second functional renal MRI imaging will take place 12 months (±30 days) after the 1st study scan day. Renal function assessment will occur±7 days either side of the scan with an Iohexol clearance test.


Recruitment information / eligibility

Status Recruiting
Enrollment 50
Est. completion date December 2020
Est. primary completion date December 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years to 95 Years
Eligibility Inclusion Criteria:

AKI Patients:

- Acute Kidney Injury stage 2/3 (duration >24 hours) including patients requiring renal replacement therapy

- >18 years & < 95 years

- Able to give informed consent

CKD Patients:

- Patients with CKD Stage 3 - 4 (e GFR> 20 and <60 ml/min)

- >18 years & < 95 years

- Able to give informed consent

Exclusion Criteria:

AKI Patients:

- Renal transplant

- Contraindications to MRI e.g. claustrophobia, cardiac pacemaker, metallic fragments or implants

- Pregnancy or breast feeding or intending pregnancy

- Unable to give consent or understand written information

- Pre-existing CKD of any stage as per eGFR

- Obstructive uropathy

- AKI duration <24hrs, in the opinion of the investigator

- Not medically fit for transfer to MRI scan, in the opinion of the clinical team or the investigator

- Iodine allergy

- Patients unable to comply with basic verbal English commands whilst in scanner due to special communication needs

CKD Patients:

- Renal transplant

- Contraindications to MRI e.g. claustrophobia, cardiac pacemaker, metallic fragments or implants

- Pregnancy or breast feeding or intending pregnancy

- Unable to give consent or understand written information

- Unstable CKD; AKI Stage 1 or more or other unplanned hospital admission within the last 90 days

- Iodine allergy

- Patients unable to comply with basic verbal English commands whilst in scanner due to special communication needs

Study Design


Related Conditions & MeSH terms


Intervention

Other:
3 Tesla multiparametric MR
Renal MRI Scan to assess blood flow, perfusion, oxygenation and microstructure (MR T1 relaxation time and diffusion). Each patient will have 3 renal MRI scans.
renal histopathology scoring
Blinded fibrosis scoring of renal histopathology (If biopsy performed for clinical indication)
Biological:
Blood and urine sampling
Blood and urine sampling around scan sessions; this will include routine patient care biochemistry and haematology panel, urine protein and albumin measurements, stored plasma/serum/urine for subsequent analysis
Iohexol clearance test
Iohexol clearance to measure GFR within 1 week of the scan session

Locations

Country Name City State
United Kingdom Royal Derby Hospital Derby East Midlands

Sponsors (1)

Lead Sponsor Collaborator
University of Nottingham

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary The difference between volume (mls) MR parameter between healthy volunteers and patients with CKD and AKI Examining the difference in volume (mls) T1 (ms) between the 3 groups using PRISM, SPSS, Stata and Matlab 3 years
Primary The difference between T1 (ms) MR parameter between healthy volunteers and patients with CKD and AKI Examining the difference in T1 (ms) between the 3 groups using PRISM, SPSS, Stata and Matlab 3 years
Primary The difference between Diffusion weighted imaging MR parameter between healthy volunteers and patients with CKD and AKI Examining the difference in ADC and D(ms) between the 3 groups using PRISM, SPSS, Stata and Matlab 3 years
Secondary Correlations between structural T1 (ms) and blinded renal biopsy measurements Sirius red fibrosis scoring (%) Vs T1(ms) 3 years
Secondary Correlations between structural MR measurement: T1(ms) and creatinine(µmols), T1 (ms) vs creatinine (µmols) 3 years
Secondary Correlations between structural diffusion weighted imaging and blinded renal biopsy measurements Sirius red fibrosis scoring (%) Vs ADC and D (ms) 3 years
Secondary Correlations between structural MR measurement: diffusion weighted imaging and eGFR mls/min.1.73m ADC and D (ms) vs eGFR mls/min.1.73m 3 years
See also
  Status Clinical Trial Phase
Active, not recruiting NCT03672110 - Slow and Low Start of a Tacrolimus Once Daily Immunosuppressive Regimen Phase 3
Completed NCT01545531 - Two-Point Measurement of Glomerular Filtration Rate by Iohexol Plasma Disappearance N/A
Recruiting NCT05700903 - Contributions to Hypertension With Androgen Deprivation Therapy Phase 4
Completed NCT03717883 - ADPKD Alterations in Hepatic Transporter Function
Withdrawn NCT04556721 - A Pharmacokinetic Study of Sugammadex in Dialysis Patients Phase 1
Active, not recruiting NCT04078750 - PLATO - Medication Adherence in Transplant Recipients N/A
Not yet recruiting NCT04531124 - Cardiovascular and Renal Outcomes of Integrated Management of Blood Pressure and Other Cardiometabolic Risks in Hypertensives
Completed NCT03107195 - Biokinetics Study of Tc-99m DMSA in Pediatric Molecular Imaging
Completed NCT03463148 - Validation of a Sensor for Non-Invasive Measurements
Withdrawn NCT01468259 - A Multi-Center, Open-Label Study Phase 1
Completed NCT01256983 - Light for Renal Transplant Recipients Having a Sleep-Wake Dysregulation Phase 0
Completed NCT06070337 - H-Guard Pilot Safety Evaluation in Haemodialysis Patients N/A
Completed NCT05593211 - Assess Safety and Performance of the Kronos Electrocautery Device for Electrocautery Procedures Following Coaxial Biopsy Procedures N/A
Completed NCT03242343 - VasQ External Support for Arteriovenous Fistula N/A
Completed NCT03438123 - Data Collection Study for the Spectrum Dynamics Multi-purpose CZT SPECT Camera N/A
Completed NCT01334333 - Comparison of Medication Adherence Between Once and Twice Daily Tacrolimus in Stable Renal Transplant Recipients Phase 4
Recruiting NCT05443321 - Advancing Health Information Exchange (HIE) During Inter-hospital Transfer (IHT) to Improve Patient Outcomes N/A
Completed NCT04407182 - Safety and Efficacy of Viusid and Asbrip in Hospitalized Patients Infected by SARS-Cov-2 With COVID-19 Phase 2
Not yet recruiting NCT06419270 - Cardiovascular, Renal, and Skeletal Complications in Patients With Post-Surgical Hypoparathyroidism
Not yet recruiting NCT04834089 - Clinical Trial for Assessment of Anti-SARS-CoV-2 Serum for Early Treatment of COVID-19 Cases Phase 1/Phase 2